Cargando…
Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer
Gastric cancer is a leading cause of cancer-related deaths worldwide. Recently, clinical studies have demonstrated that many of those with advanced gastric cancer are responsive to immune checkpoint antibody therapy, although the median survival even with these new agents is less than 12 months for...
Autores principales: | Smith, Jill P., Cao, Hong, Chen, Wenqiang, Mahmood, Kanwal, Phillips, Teresa, Sutton, Lynda, Cato, Allen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672297/ https://www.ncbi.nlm.nih.gov/pubmed/34926305 http://dx.doi.org/10.3389/fonc.2021.788875 |
Ejemplares similares
-
The central role of gastrin in gastric cancer
por: Waldum, Helge, et al.
Publicado: (2023) -
Gastrin and Gastric Cancer
por: Smith, Jill P., et al.
Publicado: (2017) -
Gastrin and Gastric Cancer
por: Waldum, Helge L., et al.
Publicado: (2017) -
Human gastrin- releasing peptide receptor expression in women with uterine cervix cancer
por: Kunos, Charles A., et al.
Publicado: (2023) -
Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
por: Xu, Wei, et al.
Publicado: (2021)